Background Bacterial co-pathogens are commonly identified in viral respiratory infections
and are important causes of morbidity and mortality. The prevalence of bacterial infection in …

Background The proportion of patients infected with SARS-CoV-2 that are prescribed
antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance. …

Background COVID-19 and antimicrobial resistance (AMR) are two intersecting global public
health crises. Objective We aimed to describe the impact of the COVID-19 pandemic on …

Background Frequent use of antibiotics in patients with COVID-19 threatens to exacerbate
antimicrobial resistance. We aimed to establish the prevalence and predictors of bacterial …

A recent publication in CMAJ1 highlights the critical need for timely, accurate and accessible
epidemiologic data for the ongoing coronavirus disease 2019 (COVID-19) outbreak to …

Background The prevalence of bacterial infection in patients with COVID-19 is low, however,
empiric antibiotic use is high. Risk stratification may be needed to minimize unnecessary …

Background Governments have implemented population-wide physical distancing measures
to control COVID-19, but metrics evaluating their effectiveness are not readily available. …

Background: Lyme disease (LD) is a bacterial infection transmitted by the black-legged tick (Ixodes
scapularis) in eastern North America. It is an emerging disease in Canada due to the …

The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological
information to inform public health decision-making and outbreak control efforts. In …

BACKGROUND: Nonpharmaceutical interventions remain the primary means of controlling
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) until vaccination coverage …